BridgeMD
Compares treatment options for Crohn Disease
Official title KONO-S Anastomosis Compared to Conventional Ileocolonic Anastomosis to Reduce Recurrence in Crohn's Disease
ClinicalTrials.gov ID: NCT05974358
What this study is testing
- What it's testing
- Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) currently affecting one person in a thousand in France. It can lead to numerous digestive complications such as fistulas, abscesses or stenosis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Adult patient ≥ 18 years and ≤75 years
- With Crohn's disease.
- Requiring a first ileocolonic resection: fistulizing, abscessed, or stenosing disease or disease refractory to medical treatment.
- Affiliated to the French social security system.
You likely can't join if
- Previous ileocolonic resection
- Contraindication to postoperative endoscopy.
- Anastomosis with a planned defunctioning protective stoma.
- Emergency surgery (peritonitis).
- Lack of consent to the study.
- Pregnant patients.
See the full eligibility criteria
- Adult patient ≥ 18 years and ≤75 years
- With Crohn's disease.
- Requiring a first ileocolonic resection: fistulizing, abscessed, or stenosing disease or disease refractory to medical treatment.
- Affiliated to the French social security system.
- Previous ileocolonic resection
- Contraindication to postoperative endoscopy.
- Anastomosis with a planned defunctioning protective stoma.
- Emergency surgery (peritonitis).
- Lack of consent to the study.
- Pregnant patients.
- Refusal to participate or inability to provide informed consent.
- Patient under legal protection (individuals under guardianship by court order)
The study team makes the final eligibility decision.
Where it's taking place
- Besançon, France
- Bordeaux, France
- Grenoble, France
- Lille, France
- Lyon, France
- Marseille, France
- Nancy, France
- Nantes, France
- Paris, France
- Rennes, France
- Strasbourg, France
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Besançon, France; Bordeaux, France; Grenoble, France; Lille, France; Lyon, France; Marseille, France and 6 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.